Mainstream

Thermo Fisher raises 2025 guidance to $44.2B revenue and $22.84 EPS amid strong pharma and biotech momentum

Thermo Fisher raises 2025 guidance to $44.2B revenue and $22.84 EPS amid strong pharma and biotech momentum

Post Contenttmo, tmo:caRead More

You might also be interested in reading CME Unleashing XRP Options After $16B Futures Rally Signals Strong Institutional Demand.

July 23, 2025
In Mainstream